RaySearch Laboratories AB (publ) announced that the Paul Scherrer Institute (PSI) in Switzerland has placed an order for the treatment planning system RayStation. Renowned worldwide for its treatment of cancers with proton therapy, PSI has selected RayStation as the treatment planning system for its clinical operations. PSI is equipped with three gantries and a fixed horizontal beam line room for ocular treatments.

Two of the gantries, of which one is in-house developed, operate clinically while the third is dedicated to research. Alongside the procurement of RayStation, RaySearch and PSI have the intent of engaging in a collaborative research initiative. This partnership will focus on a range of strategic areas, including online adaptive proton therapy.